Under the Pollution Prevention Act of 1990 (PPA), TRI collects information to track industry progress in reducing waste generation and moving towards safer waste management alternatives. Measures that facilities have taken to prevent pollution and reduce the amount of toxic chemicals entering the environment are shown in the table below. Although factors other than these reported practices contribute to year-to-year changes in releases, results are sorted by largest reduction in order to facilitate identification of pollution prevention successes. View the to learn about this report's features.

List of Facilities in TRI submitting Pollution Prevention Information for Selected Criteria:

Year: between 2016 and 2024

P2 Text Filters: Only show information about source reduction activities Show information about source reduction AND other environmental practices Exclude facilities that reported activity codes but no text descriptions Show information on barriers to implementing source reduction activities Show ALL information reported in pollution prevention data fields Year-to-Year Comparison: Total Waste Total Release [displayed currently] Air Release Land Release Water Release

TRI Facility ID	Facility Name	Address	Chemical Name	Industry	Year	Prior Year Release *	Current Year Release *	Percent Change	Pollution Prevention Information (Activity Codes/Text/[Reduction])	P2 Report	P2 Report URL
27317RRWNT200CO	ARROW INTERNATIONAL INC (TELEFLEX INC)	312 COMMERCE PL, ASHEBORO, NC 27203	Ethylene oxide	339112: Surgical and Medical Instrument Manufacturing	2020	144.00	133.00	-7.64	Source Reduction: Ethylene oxide sterilization is required to meet FDA requirements. Arrow International, Inc. implemented the following waste reduction and elimination plan for 2020: 1. Used only 100% ethylene oxide as a sterilant. Ethylene oxide is oxidized, post-process to carbon dioxide and water. 2. Maximized the utilization of the sterilizers by designing product pallet stacking configurations using a software program specifically designed to volumetrically optimize product loading. 3. Product batches were built to completely fill each pallet and a full load of 8 pallets was run through each sterilization cycle to minimize the amount of ethylene oxide used and maximize efficiency. 4. The sterilization processes are designed and validated to use the lowest effective concentration of ethylene oxide necessary to sterilize our products. 5. Standard operating procedures for each sterilization cycle mandate test protocols designed to detect any leaks in the system prior to introduction of ethylene oxide into the sterilization chamber. Ethylene oxide is introduced to each cycle only after the test cycle is successfully complete for every cycle run. If a problem is detected, the cycle is aborted prior to the introduction of ethylene oxide into the chamber, reducing waste and eliminating any potential leakage due to equipment failure.		//enviro.epa.gov/enviro/P2_EF_Query.p2_report?FacilityId=27317RRWNT200CO&ChemicalId=0000075218&ReportingYear=2020&DocCtrlNum=1320218616100&Opt=0
27317RRWNT200CO	ARROW INTERNATIONAL INC (TELEFLEX INC)	312 COMMERCE PL, ASHEBORO, NC 27203	Ethylene oxide	339112: Surgical and Medical Instrument Manufacturing	2021	133.00	123.00	-7.52	Source Reduction: Source Reduction - Ethylene oxide sterilization is required to meet FDA requirements. Arrow International, Inc. implemented the following waste reduction and elimination plan for 2021: 1. Used only 100% ethylene oxide as a sterilant. Ethylene oxide is oxidized, post-process to carbon dioxide and water. 2. Maximized the utilization of the sterilizers by designing product pallet stacking configurations using a software program specifically designed to volumetrically optimize product loading. 3. Product batches were built to completely fill each pallet and a full load of 8 pallets was run through each sterilization cycle to minimize the amount of ethylene oxide used and maximize efficiency. 4. The sterilization processes are designed and validated to use the lowest effective concentration of ethylene oxide necessary to sterilize our products. 5. Standard operating procedures for each sterilization cycle mandate test protocols designed to detect any leaks in the system prior to introduction of ethylene oxide into the sterilization chamber. Ethylene oxide is introduced to each cycle only after the test cycle is successfully complete for every cycle run. If a problem is detected, the cycle is aborted prior to the introduction of ethylene oxide into the chamber, reducing waste and eliminating any potential leakage due to equipment failure.		//enviro.epa.gov/enviro/P2_EF_Query.p2_report?FacilityId=27317RRWNT200CO&ChemicalId=0000075218&ReportingYear=2021&DocCtrlNum=1321219582513&Opt=0
27317RRWNT200CO	ARROW INTERNATIONAL INC (TELEFLEX INC)	312 COMMERCE PL, ASHEBORO, NC 27203	Ethylene oxide	339112: Surgical and Medical Instrument Manufacturing	2019	140.00	144.00	2.86	Source Reduction: Ethylene oxide sterilization is required to meet FDA requirements. Arrow International, Inc. implemented the following waste reduction and elimination plan for 2019: 1. Used only 100% ethylene oxide as a sterilant. Ethylene oxide is oxidized, post-process tocarbon dioxide and water. 2. Maximized the utilization of the sterilizers by designing product pallet stacking configurations using a software program specifically designed to volumetrically optimize product loading. 3. Product batches were built to completelyfill each pallet and a full load of 8 pallets was run through each sterilization cycle to minimize the amount of ethylene oxide used and maximize efficiency. 4. The sterilization processes are designed and validated to use the lowest effective concentration of ethylene oxide necessary to sterilize our products. 5. Standard operating procedures for each sterilization cycle mandate test protocols designed to detect any leaks in the system prior to introduction of ethylene oxide into the sterilization chamber. Ethylene oxide is introduced to each cycle only after the test cycle is successfully complete for every cycle run. If a problem is detected, the cycle is aborted prior to the introduction of ethylene oxide into the chamber, reducing waste and eliminating any potential leakage due to equipment failure.		//enviro.epa.gov/enviro/P2_EF_Query.p2_report?FacilityId=27317RRWNT200CO&ChemicalId=0000075218&ReportingYear=2019&DocCtrlNum=1319217658867&Opt=0